Clinical Trial Update: KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial comparing KIVEXA (abacavir/lamivudine) vs TRUVADA (emtricitabine/tenofovir) both with efavirenz in ART-naive HIV patients. Results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kivexa (abacavir/lamivudine)
• Sustiva (efavirenz)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2010-10-15